Target intelligence / Profile preview

Cytochrome c, somatic pseudogene 52 (CYCSP52)

Target
CYCSP52
Molecular classification
Other (Processed pseudogene)
01

Overview

Cytochrome c, somatic pseudogene 52 (CYCSP52) is a noncoding genomic locus that shares substantial sequence similarity with the functional cytochrome c gene but incorporates mutations and/or deletions that prevent it from encoding the active cytochrome c protein. Pseudogenes were traditionally believed to be nonfunctional "junk" DNA, but recent data show many are transcribed and may regulate gene expression by acting as competitive endogenous RNAs, microRNA sponges, or via RNA interference pathways. Some pseudogenes—including those of other cancer-related genes—play roles in disease as noncoding RNA regulators. However, for CYCSP52 specifically, no known protein-coding or regulatory function is confirmed, and it is not considered a drug target or direct biomarker. Its biological significance lies chiefly within the broader context of noncoding RNA and pseudogene network regulation[3][4][5].

Other names
HCP2HC6cytochrome c, somatic pseudogene 52somatic cytochrome c (HC6) processed pseudogeneCYCSP52
02

Mechanism of action

Not applicable. Pseudogenes do not encode proteins targeted by drugs.

03

Biological functions

Regulation of gene expression (via noncoding RNA mechanisms such as microRNA decoy/sponging, and possibly RNA interference)Possible involvement in noncoding RNA networks (competing for microRNA binding)
04

Disease associations

Emerging evidence suggests roles in cancer progression (through regulatory impacts on coding genes)Other roles are possible but not conclusively defined for this specific pseudogene.

Beyond the preview

Go deeper on Cytochrome c, somatic pseudogene 52 (CYCSP52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c, somatic pseudogene 52 (CYCSP52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call